Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases

Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases

Lipid and immune pathways are crucial in the pathophysiology of metabolic and cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to immunity and inflammation, thus holding a key role in the emergence and progression of frequent diseases such as obesity, diabet...

Full description

Bibliographic Details
Main Authors:	Thomas Sonnweber, Alex Pizzini, Manfred Nairz, Günter Weiss, Ivan Tancevski
Format:	Article
Language:	English
Published:	MDPI AG 2018-10-01
Series:	International Journal of Molecular Sciences
Subjects:	arachidonic acid eicosanoids metabolic disease obesity nonalcoholic fatty liver disease diabetes atherosclerosis cardiovascular disease cholesterol
Online Access:	https://www.mdpi.com/1422-0067/19/11/3285

Similar Items

Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: Min-Kyu Kang, et al.
Published: (2021-05-01)

Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis1
by: Rohit Loomba, et al.
Published: (2015-01-01)

Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
by: Jorge H. Capdevila, et al.
Published: (2000-02-01)

The association of obesity and liver enzyme activities in a student population at increased risk for cardiovascular disease
by: Čolak Emina, et al.
Published: (2013-01-01)

The association between nonalcoholic fatty liver disease and cardiovascular disease: A window of opportunity
by: Narendra Singh Choudhary, et al.
Published: (2021-01-01)

Concentrations of Proinflammatory Mediators of The Arachidonic Acid Cascade in Serum of Sheep with Natural Zearalenone Intoxication
by: Kostro Krzysztof, et al.
Published: (2012-03-01)

Citrus limonin glucoside supplementation decreased biomarkers of liver disease and inflammation in overweight human adults
by: Darshan S. Kelley, et al.
Published: (2015-01-01)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
by: Eun Jeong Kim, et al.
Published: (2019-01-01)

Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress
by: Sarayu A. Pai, et al.
Published: (2019-03-01)

The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: A Mendelian randomization study
by: Ting Zhang, et al.
Published: (2021-01-01)

Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
by: Tingting Du, et al.
Published: (2017-12-01)

Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation[S]
by: Chin Fung Kelvin Kan, et al.
Published: (2014-08-01)

Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
by: Fatema Abu Bakr Abdel-Moez, et al.
Published: (2019-01-01)

Current approaches to diagnosing and treating nonalcoholic fatty liver disease
by: O M Drapkina, et al.
Published: (2014-10-01)

Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease
by: Marek Waluga, et al.
Published: (2017-09-01)

Arachidonate metabolism and the signaling pathway of induction of apoptosis by oxidized LDL/oxysterol
by: Sankhavaram R. Panini, et al.
Published: (2001-10-01)

Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis[S]
by: Lin Jia, et al.
Published: (2010-11-01)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
by: Noriyo Urata, et al.
Published: (2020-09-01)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
by: Na Young Lee, et al.
Published: (2021-01-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male <i>Ldlr <sup>-/-</sup></i> Mice
by: Manuel García-Jaramillo, et al.
Published: (2019-10-01)

Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study
by: Akinyemi Oni-Orisan, et al.
Published: (2016-01-01)

Risk factors for cardiovascular disease in patients with non-alcoholic fatty liver disease with polymorbidity
by: E. V. Sevostyanova, et al.
Published: (2019-11-01)

The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms
by: Rachfal AW, et al.
Published: (2021-03-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients
by: Yu‐Wen Pan, et al.
Published: (2019-12-01)

Prevalence of Fatty Liver Disease in Obese Children and Adolescents Who Referred to Pediatric Clinic of Kashan University of Medical Sciences, Iran (2012-2013)
by: K Shiasi Arani, et al.
Published: (2013-09-01)

Ultrasonographic features associated with diffuse hepatosteatosis among diabetic obese and normal body mass index patients
by: Mahjabeen Liaqat, et al.
Published: (2020-01-01)

Arachidonic Acid in Human Milk
by: Norman Salem, et al.
Published: (2020-02-01)

Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD
by: Ran Jin, et al.
Published: (2014-08-01)

Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients
by: Ivana Mikolasevic, et al.
Published: (2014-09-01)

Epidemiology and natural history of NAFLD
by: Della Corte Claudia, et al.
Published: (2015-01-01)

Prevalence and Determinants of Hepatic Steatosis in Young Adult Women
by: Xanthakos, Stavra A.
Published: (2006)

Phospholipid, arachidonate and eicosanoid signaling in schizophrenia
by: Messamore Erik, et al.
Published: (2016-01-01)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
by: Fan Y, et al.
Published: (2021-07-01)

Electrocardiographic and echocardiographic changes in nonalcoholic fatty liver disease
by: Ahmed S Elsawaby, et al.
Published: (2019-01-01)

Inhibition of 5-Lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model
by: Kuifen Ma, et al.
Published: (2017-11-01)

Carotid intima–media thickness, nonalcoholic fatty liver disease, and hemoglobin A1c are independently associated with the severity of psoriasis
by: Rahime Inci, et al.
Published: (2016-09-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
by: Hassan Pakravan, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_9vd9h5cjrtccqjn24id5c321qr